Paper36906608
Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development.
Zhao N and 7 others. Signal Transduct Target Ther, 2023. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development. Papers, record 36906608. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36906608
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development.
- PubMed
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Engineering | Major topic |
| Drug Development | Major topic |
| Synthetic Biology |
Source PubMed
References305
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19461664 | The second wave of synthetic biology: from modules to systems. | Nat Rev Mol Cell Biol | 2009 | https://conductscience.org/library/papers/19461664 | PubMed |
| 2 | 22069713 | Cycle inhibiting factors (cifs): cyclomodulins that usurp the ubiquitin-dependent degradation pathway of host cells. | Toxins (Basel) | 2011 | https://conductscience.org/library/papers/22069713 | PubMed |
| 3 | 31267108 | Gene therapy's next installment. | Nat Biotechnol | 2019 | https://conductscience.org/library/papers/31267108 | PubMed |
| 4 | 26394633 | Bivalent rLP2086 Vaccine (Trumenba(®)): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10-25 Years. | BioDrugs | 2015 | https://conductscience.org/library/papers/26394633 | PubMed |
| 5 | 39190688 | Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system. | PLoS One | 2024 | https://conductscience.org/library/papers/39190688 | PubMed |
| 6 | 32333225 | Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer's disease and Parkinson's disease. | AMB Express | 2020 | https://conductscience.org/library/papers/32333225 | PubMed |
| 7 | 33382154 | Therapeutic applications of lysostaphin against Staphylococcus aureus. | J Appl Microbiol | 2021 | https://conductscience.org/library/papers/33382154 | PubMed |
| 8 | 28939078 | Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma. | Oral Oncol | 2017 | https://conductscience.org/library/papers/28939078 | PubMed |
| 9 | 30366260 | Gut microbiome and type 2 diabetes: where we are and where to go? | J Nutr Biochem | 2019 | https://conductscience.org/library/papers/30366260 | PubMed |
| 10 | 28596569 | Targeting Bacillus anthracis toxicity with a genetically selected inhibitor of the PA/CMG2 protein-protein interaction. | Sci Rep | 2017 | https://conductscience.org/library/papers/28596569 | PubMed |
| 11 | 25951391 | Rapid Detection of Bacillus anthracis in Complex Food Matrices Using Phage-Mediated Bioluminescence. | J Food Prot | 2015 | https://conductscience.org/library/papers/25951391 | PubMed |
| 12 | 33731300 | Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate. | Biochim Biophys Acta Gen Subj | 2021 | https://conductscience.org/library/papers/33731300 | PubMed |
| 13 | 33538585 | Synthetic Biology and Computer-Based Frameworks for Antimicrobial Peptide Discovery. | ACS Nano | 2021 | https://conductscience.org/library/papers/33538585 | PubMed |
| 14 | 33571426 | Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics. | Cell | 2021 | https://conductscience.org/library/papers/33571426 | PubMed |
| 15 | 28634323 | Intestinal microbial dysbiosis aggravates the progression of Alzheimer's disease in Drosophila. | Nat Commun | 2017 | https://conductscience.org/library/papers/28634323 | PubMed |
| 16 | 30833243 | Mitigation of environmental pollution by genetically engineered bacteria - Current challenges and future perspectives. | Sci Total Environ | 2019 | https://conductscience.org/library/papers/30833243 | PubMed |
| 17 | 20807808 | Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. | Cancer Res | 2010 | https://conductscience.org/library/papers/20807808 | PubMed |
| 18 | 33815126 | Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/33815126 | PubMed |
| 19 | 31992629 | Stable Neutralization of a Virulence Factor in Bacteria Using Temperate Phage in the Mammalian Gut. | mSystems | 2020 | https://conductscience.org/library/papers/31992629 | PubMed |
| 20 | 21885773 | Synthetic biology moving into the clinic. | Science | 2011 | https://conductscience.org/library/papers/21885773 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947991 | Engineering next-generation CAR-NK cells for hematological malignancies: genome editing, synthetic biology, and precision immunotherapy. | Front Genome Ed | 2026 | https://conductscience.org/library/papers/42947991 | PubMed |
| 42354930 | Global Probiotic Markets Meet Synthetic Biology: Translational Challenges and Escherichia coli Nissle 1917 as a Model Chassis. | Microorganisms | 2026 | https://conductscience.org/library/papers/42354930 | PubMed |
| 42285989 | Decoding phage communication: molecular networks, evolutionary dynamics, and therapeutic applications. | NPJ Biofilms Microbiomes | 2026 | https://conductscience.org/library/papers/42285989 | PubMed |
| 42057131 | Engineered live bacteria for liver diseases and gut-liver axis disorders: from genetic modification to advanced delivery systems. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42057131 | PubMed |
| 41982812 | Biomaterials Based on Bacteria for Cancer Clinical Therapy. | Biomater Res | 2026 | https://conductscience.org/library/papers/41982812 | PubMed |
| 41858590 | The Cross-Species Implantable ATP Battery Inspired by Photosynthesis for Application in Diseases. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41858590 | PubMed |
| 41685627 | Dual-Key Genetic Circuit Enables Stable and Self-Regulated Engineered Bacteria for the Treatment of Ulcerative Colitis. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41685627 | PubMed |
| 41637060 | Logic-Gated HSV-TK/GCV Suicide Gene Circuit for Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41637060 | PubMed |
| 41613450 | Gene circuit-based sensors. | Fundam Res | 2025 | https://conductscience.org/library/papers/41613450 | PubMed |
| 41601664 | Breast milk-saliva interactions in shaping early mucosal immunity. | Front Immunol | 2025 | https://conductscience.org/library/papers/41601664 | PubMed |
| 41599202 | CRISPR-Cas-Mediated Reprogramming Strategies to Overcome Antimicrobial Resistance. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41599202 | PubMed |
| 41487532 | Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapy. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41487532 | PubMed |
| 41486563 | A Natural Sweetener-inducible Genetic Switch Controls Therapeutic Protein Expression in Mammals. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41486563 | PubMed |
| 41454921 | Microbial Systems Enhancing CAR-Based Therapies: A Synthetic Biology Paradigm for Next-Generation Cancer Immunotherapy. | Curr Microbiol | 2025 | https://conductscience.org/library/papers/41454921 | PubMed |
| 41278660 | Small amphiphilic DNA for programmable transmembrane signaling and amplification. | bioRxiv | 2025 | https://conductscience.org/library/papers/41278660 | PubMed |
| 41230802 | Chemical Surface Modification Tolerance of Primary and Immortalized Macrophages and Stem Cells. | Chembiochem | 2025 | https://conductscience.org/library/papers/41230802 | PubMed |
| 41188868 | Engineered probiotics: a new era in treating inflammatory bowel disease. | J Transl Med | 2025 | https://conductscience.org/library/papers/41188868 | PubMed |
| 41149908 | The Role of microRNAs and Cell-Free DNAs in Fungal Infections: Systematic Review and Meta-Analysis of the Literature. | J Fungi (Basel) | 2025 | https://conductscience.org/library/papers/41149908 | PubMed |
| 41011531 | Neutralizing Antibodies vs. Viruses: Interacting Mechanisms and Escape Tactics. | Microorganisms | 2025 | https://conductscience.org/library/papers/41011531 | PubMed |
| 40915654 | A Safe and Versatile Minicell Platform Derived from Lactiplantibacillus plantarum for Biotechnological Applications. | J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/40915654 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36906608
GET https://conductscience.org/api/papers/v1/36906608/references?page=2